The selling stockholder has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares to cover over-allotments, if any.
The Company said that it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholder in this offering, but will pay certain expenses.
J.P. Morgan Securities Inc. and BofA Merrill Lynch are the joint book-running managers for the offering. William Blair & Company is co-lead manager and Jefferies & Company, Inc. and Credit Suisse Securities (USA) are co-managers.
The offering is being made under a shelf registration statement filed with the Securities and Exchange Commission, and is expected to close on August 12.
Sirona develops, manufactures, and markets a complete line of dental products, including the CAD/CAM restoration equipment (CEREC), digital and film-based intra-oral, panoramic and cephalometric X-ray imaging systems, dental treatment centers and handpieces.
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index